In Glaucoma the Upregulated Truncated TrkC.T1 Receptor Isoform in Glia Causes Increased TNF-α Production, Leading to Retinal Ganglion Cell Death
- 1 December 2010
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 51 (12), 6639-6651
- https://doi.org/10.1167/iovs.10-5431
Abstract
Purpose.: Glaucoma is a distinct neuropathy characterized by the chronic and progressive death of retinal ganglion cells (RGCs). The etiology of RGC death remains unknown. Risk factors for glaucomatous RGC death are elevated intraocular pressure and glial production of tumor necrosis factor-alpha (TNF-α). Previously, the authors showed that glaucoma causes a rapid upregulation of a neurotrophin receptor truncated isoform lacking the kinase domain, TrkC.T1, in retina. Here they examined the biological role of TrkC.T1 during glaucoma progression. Methods.: Rat and mouse models of chronic ocular hypertension were used. Immunofluorescence Western blot analysis and in situ mRNA hybridization were used to identify cells upregulating TrkC.T1. A genetic model of engineered mice lacking TrkC.T1 (TrkC.T1−/−) was used to validate a role for this receptor in glaucoma. Pharmacologic studies were conducted to evaluate intravitreal delivery of agonists or antagonists of TrkC.T1, compared with controls, during glaucoma. Surviving RGCs were quantified by retrograde-labeling techniques. Production of neurotoxic TNF-α and α2 macroglobulin were quantified. Results.: TrkC.T1 was upregulated in retinal glia, with a pattern similar to that of TNF-α. TrkC.T1−/− mice had normal retinas. However, during experimental glaucoma, TrkC.T1−/− mice had lower rates of RGC death and produced less TNF-α than wild-type littermates. In rats with glaucoma, the pharmacologic use of TrkC antagonists delayed RGC death and reduced the production of retinal TNF-α. Conclusions.: TrkC.T1 is implicated in glaucomatous RGC death through the control of glial TNF-α production. Overall, the data point to a paracrine mechanism whereby elevated intraocular pressure upregulated glial TrkC.T1 expression in glia; TrkC.T1 controlled glial TNF-α production, and TNF-α caused RGC death.Keywords
This publication has 50 references indexed in Scilit:
- A peptidomimetic of NT-3 acts as a TrkC antagonistPeptides, 2009
- Bivalent Peptidomimetic Ligands of TrkC Are Biased Agonists and Selectively Induce Neuritogenesis or Potentiate Neurotrophin-3 Trophic SignalsACS Chemical Biology, 2009
- Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cellsMolecular and Cellular Neuroscience, 2009
- Induced Autoimmunity to Heat Shock Proteins Elicits Glaucomatous Loss of Retinal Ganglion Cell Neurons via Activated T-Cell-Derived Fas-LigandJournal of Neuroscience, 2008
- α2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in GlaucomaOnline Journal of Public Health Informatics, 2008
- Targeting amyloid-β in glaucoma treatmentProceedings of the National Academy of Sciences of the United States of America, 2007
- A kinase-deficient TrkC receptor isoform activates Arf6–Rac1 signaling through the scaffold protein tamalinThe Journal of cell biology, 2006
- Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertensionJournal of Neurobiology, 2004
- Glaucoma ocular Alzheimer s diseaseFrontiers in Bioscience-Landmark, 2003
- Genomic characterization of the human trkC geneOncogene, 1998